Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events (IDEAL-Study).
Phase of Trial: Phase IV
Latest Information Update: 29 Nov 2016
At a glance
- Drugs Atazanavir (Primary) ; Ritonavir (Primary) ; Atazanavir/ritonavir; Emtricitabine; Tenofovir disoproxil fumarate
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms IDEAL
- 10 Jun 2017 Biomarkers information updated
- 28 May 2013 NCT reports actual initiation date is 1 Aug 2011.
- 28 May 2013 Planned End Date changed from 1 Aug 2013 to 1 Oct 2016 as reported by ClinicalTrials.gov.